- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Segment 4 - Payer Panel Pathway Recommendations
Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Dr Sonnad asked panelists about the participants on payer panels who determine the cost-effectiveness of pathways.
Dr Malin said WellPoint uses an internal team of oncologists and pharmacists who collaborate on pathway recommendations. They also utilize an external advisory group of oncologists from community practices and academic centers who review the organization's outcome summaries and evidence of proposed pathways.
“We also make our pathways available on the Web so anyone can download them and there’s an e-mail address as well on the pathways themselves when you download them — any provider can provide feedback to us about the pathways,” Dr Malin said. They will monitor this feedback to determine whether certain patients may not require a pathway.
Dr Yu said that there should be ongoing and regular reviews of pathway guidelines, if they’re not already established. These are useful to determine variations and changes in pathway regimens.
Moving Evidence From Research to Practice: Q&A With Ken Cohen, MD
June 23rd 2025In 2025, each issue of Population Health, Equity & Outcomes will feature a profile of a health system leader transforming care in their area of expertise. This issue spotlights a conversation with Ken Cohen, MD, executive director of translational research at Optum Health.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
